Osteosarcoma: a review of current and future therapeutic approaches.
Reads0
Chats0
TLDR
Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults as mentioned in this paper, it is characterized by a high degree of malignancies, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally.Abstract:
Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options.read more
Citations
More filters
Journal ArticleDOI
Naringenin: A potential flavonoid phytochemical for cancer therapy.
Mahzad Motallebi,Mohammed Bhia,Huda Fatima Rajani,Iman Bhia,Hadi Tabarraei,Niloufar Mohammadkhani,Miguel Pereira-Silva,Maryam Sadat Kasaii,Saeedeh Nouri-Majd,Anna Lena Mueller,Francisco Veiga,Ana Cláudia Paiva-Santos,Mehdi Shakibaei +12 more
TL;DR: Naringenin is an important phytochemical which belongs to the flavanone group of polyphenols, and is found mainly in citrus fruits like grapefruits and others such as tomatoes and cherries plus medicinal plants derived food as mentioned in this paper .
Journal ArticleDOI
Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review
Adrian Badila,D. Rădulescu,Adelina-Gabriela Niculescu,Alexandru Mihai Grumezescu,Alexandru Mihai Grumezescu,Marius Radulescu,Adrian Radu Rădulescu +6 more
TL;DR: In this paper, the types of bone tumors and their current treatment approaches, further focusing on the recent advances in new therapeutic alternatives, are presented, and a comparison of the two approaches is made.
Journal ArticleDOI
Anti-cancer activity of sustained release capsaicin formulations.
Justin C Merritt,Stephen D Richbart,Emily G. Moles,Ashley Cox,Kathleen C. Brown,Sarah L. Miles,Paul T. Finch,Joshua A. Hess,Maria Tria Tirona,Monica A. Valentovic,Piyali Dasgupta +10 more
TL;DR: In this paper , the physicochemical properties, bioavailability, and anti-cancer activity of capsaicin-sustained release agents have been described, and the encapsulation of Capsaicin in sustained release carriers minimizes the adverse side effects.
Journal ArticleDOI
Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy
Peng He,Sheng-Rong Xu,Zehao Guo,Peng Yuan,Yulei Liu,Yu Chen,Tiantian Zhang,Yukang Que,Yong Hu +8 more
TL;DR: The drug release of the implants prepared in this study is sustained and stable, which promotes long-term local accumulation of drugs in tumors, improves the efficacy of chemotherapy and has low toxicity to normal tissues.
Journal ArticleDOI
Chlorogenic acid for cancer prevention and therapy: Current status on efficacy and mechanisms of action.
TL;DR: Wang et al. as discussed by the authors presented a comprehensive assessment about the natural sources of chlorogenic acid, its bioavailability, metabolism, and anticancer property with an emphasis on the molecular mechanisms associated with several signaling pathways in tumor cells.
References
More filters
Journal ArticleDOI
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
TL;DR: A marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping are notable.
Journal ArticleDOI
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
TL;DR: The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem Cells.
Journal ArticleDOI
Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program
TL;DR: Osteosarcoma, which is the most common primary bone tumor, occurs most frequently in adolescents, but there is a second incidence peak among individuals aged >60 years, and direct comparisons among patients of all ages and ethnicities are not available.
Journal ArticleDOI
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
Stefan S. Bielack,Beate Kempf-Bielack,Günter Delling,G. Ulrich Exner,Silke Flege,Knut Helmke,Rainer Kotz,Mechthild Salzer-Kuntschik,M. Werner,Winfried Winkelmann,Andreas Zoubek,Heribert Jürgens,Kurt Winkler +12 more
TL;DR: Axial tumor site, male sex, and a long history of symptoms were associated with poor response to chemotherapy in univariate and multivariate analysis.
Journal Article
Tumor Chemosensitivity Conferred by Inserted Herpes Thymidine Kinase Genes: Paradigm for a Prospective Cancer Control Strategy
TL;DR: The lack of highly exploitable biochemical differences between normal tissues and some tumors can be circumvented by a strategy utilizing gene insertion prophylactically to create tissue mosaicism for drug sensitivity, thereby ensuring that any tumor arising clonally will differ from part of the normal cell population.